SCHEMBL4083049

SCHEMBL4083049

O=C(O)ON1CCC(N2Cc3ccccc3NC2=O)CC1

nearest known ligand 0.50

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CALCRL Q16602 17/20 0.50
CHRM4 P08173 2/20 0.50
RAMP1 O60894 7/20 0.49
CHRM1 P11229 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4074982 0.89 CALCRL (0.48) CALCRLCHRM4RAMP1
SCHEMBL2212650 0.89 CHRM4 (0.50) CALCRLCHRM4RAMP1CHRM1
SCHEMBL2103739 0.83 CALCRL (0.58) CALCRLCHRM4RAMP1
SCHEMBL30231301 0.83 CALCRL (0.58) CALCRLCHRM4RAMP1
SCHEMBL4072291 0.81 CALCRL (0.37) CALCRLCHRM4RAMP1CHRM1
SCHEMBL2872824 0.81 BRD4 (0.56) CALCRLCHRM4RAMP1CHRM1
SCHEMBL27752167 0.80 CHRM4 (0.57) CALCRLCHRM4RAMP1CHRM1
SCHEMBL13313600 0.80 BRD4 (0.57) CALCRLCHRM4RAMP1CHRM1
SCHEMBL13762761 0.80 CALCRL (0.54) CALCRLCHRM4RAMP1
SCHEMBL3237433 0.80 CHRM4 (0.57) CALCRLCHRM4RAMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2108648-A1 Selected CGRP antagonists, method for their manufacture and use as medicines Boehringer Ingelheim International GmbH (DE) 2009-10-14 EP disclosed
EP-1732917-B1 SELECTED CGRP ANTAGONISTS, METHODS FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA (DE) 2009-07-29 EP disclosed
EP-1558601-A1 SELECTED CGRP ANTAGONISTS, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENT BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2005-08-03 EP disclosed
WO-2004037811-A1 SELECTED CGRP ANTAGONISTS, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENT BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-05-06 WO disclosed